During the COVID-19 pandemic, multiple theories were proposed based on the observation that countries with an ongoing national Bacillus Calmette-Gue´rin (BCG) immunization programme had lower SARS-CoV-2 case rates and COVID-19 mortality than countries that had stopped BCG vaccine administration. There was, however, no evidence supporting or disputing this theory1,2 . Owing to the uncertainty on the role of BCG vaccine on the outcomes of patients with perioperative SARS-CoV-2 infection, this international study aimed to determine whether previous BCG vaccination was associated with reduced postoperative pulmonary complications (PPC) and 30-day mortality in patients undergoing surgery who developed SARS-CoV-2 infection

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection / Lapolla, P; Mingoli, A; De Toma, G; Fiori, E; La Torre, F; Sapienza, P; Brachini, G; Cirillo, B; Iannone, I; Zambon, M; Chiappini, A; Meneghini, S; Fonsi, Gb; Cicerchia, Pm; Bruzzaniti, P; Santoro, A; Frati, A; Marruzzo, G; Ribuffo, D; Familiari, P; D’Andrea, G; Picotti, V; Bàmbina, F. - In: BJS OPEN. - ISSN 2474-9842. - 5:6(2022). [10.1093/bjsopen/zrab131]

Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

Lapolla P;Mingoli A;De Toma G;Fiori E;La Torre F;Sapienza P;Brachini G;Cirillo B;Iannone I;Chiappini A;Meneghini S;Fonsi GB;Cicerchia PM;Bruzzaniti P;Santoro A;Frati A;Marruzzo G;Ribuffo D;Familiari P;Picotti V;Bàmbina F
2022

Abstract

During the COVID-19 pandemic, multiple theories were proposed based on the observation that countries with an ongoing national Bacillus Calmette-Gue´rin (BCG) immunization programme had lower SARS-CoV-2 case rates and COVID-19 mortality than countries that had stopped BCG vaccine administration. There was, however, no evidence supporting or disputing this theory1,2 . Owing to the uncertainty on the role of BCG vaccine on the outcomes of patients with perioperative SARS-CoV-2 infection, this international study aimed to determine whether previous BCG vaccination was associated with reduced postoperative pulmonary complications (PPC) and 30-day mortality in patients undergoing surgery who developed SARS-CoV-2 infection
2022
humans; SARS-CoV-2; vaccination; BCG Vaccine; COVID-19
01 Pubblicazione su rivista::01f Lettera, Nota
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection / Lapolla, P; Mingoli, A; De Toma, G; Fiori, E; La Torre, F; Sapienza, P; Brachini, G; Cirillo, B; Iannone, I; Zambon, M; Chiappini, A; Meneghini, S; Fonsi, Gb; Cicerchia, Pm; Bruzzaniti, P; Santoro, A; Frati, A; Marruzzo, G; Ribuffo, D; Familiari, P; D’Andrea, G; Picotti, V; Bàmbina, F. - In: BJS OPEN. - ISSN 2474-9842. - 5:6(2022). [10.1093/bjsopen/zrab131]
File allegati a questo prodotto
File Dimensione Formato  
Impact-of-Bacillus_2022.pdf

accesso aperto

Note: https://academic.oup.com/bjsopen/article/5/6/zrab131/6504756?login=true
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 225.31 kB
Formato Adobe PDF
225.31 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1612137
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact